Ally, B.A.S.Stallman, H.M.2025-12-172025-12-172016Journal of Pharmacy Practice and Research, 2016; 46(2):137-1381445-937X2055-2335https://hdl.handle.net/11541.2/119004Background: The prescribing and administration of clozapine as well as the monitoring requisites for patients on clozapine therapy is distinctly different from other antipsychotic drugs Aim: This study evaluated a Clozapine Decision Support Tool (CDST) to improve patient outcomes. Method: Participants were 67 inpatients at a long stay mental health facility. The CDST is a brief, two-sided multidisciplinary guide to best practice monitoring for patients on clozapine therapy. A pre- and post-intervention medication chart and prescribing audit was used to assess the level of adherence to the clozapine guidelines by clinicians. Results: There was an overall improvement in clinician adherence to guidelines with statistically significant improvements in monthly physical health monitoring and 6 monthly electrocardiography performances. Conclusion: The results of this study suggest that use of the CDST may improve clinician adherence to best practice guidelines and ultimately improve patient outcomesenCopyright 2016 The Society of Hospital Pharmacists of Australia Access Condition Notes: Postprint available after 1 July 2017mental helathclozapineprescibing auditJournal article10.1002/jppr.12082-s2.0-84974622765